Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01595620 · ClinicalTrials.gov registry record · Early Phase 1
Cannabinoid Modulation of Pain
A Early Phase 1 study, sponsored by Yale University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 6
- Enrollment target
NCT01595620 is a Early Phase 1 study that has completed, run by Yale University. The registered enrollment target is 6 participants.
The verdict
NCT01595620, a Early Phase 1 study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 6 participants
- Enrollment target
Study Summary
The purpose of this study is to test the effects of cannabinoids on pain response using a variety of human experimental pain models.
Interventions
- DRUG THC
- OTHER Electrical
- OTHER Thermal
- OTHER Capsaicin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2011-11-09 |
| Est. Completion | 2012-04-19 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01595620
The ClinicalTrials.gov registry entry for NCT01595620 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which THC is the first listed.
NCT01595620 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01595620 about?
NCT01595620 is a clinical study titled "Cannabinoid Modulation of Pain". The purpose of this study is to test the effects of cannabinoids on pain response using a variety of human experimental pain models.
What is the current status of trial NCT01595620?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 6 participants. The study started on 2011-11-09. Estimated completion is 2012-04-19.
What interventions are being tested in trial NCT01595620?
The interventions under investigation include: THC (DRUG), Electrical (OTHER), Thermal (OTHER), Capsaicin (OTHER).
Who is sponsoring clinical trial NCT01595620?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.